Four years ago, Fonar was basking in the glow of its $100-million-plus legal victory over GE in a patent issue. Whatever is left from that court battle, however, apparently is not enough. The Tail Wind Fund, which focuses on emerging growth companies,
Four years ago, Fonar was basking in the glow of its $100-million-plus legal victory over GE in a patent issue. Whatever is left from that court battle, however, apparently is not enough. The Tail Wind Fund, which focuses on emerging growth companies, has invested $4.5 million in Fonar, receiving in exchange debentures convertible to Fonar common stock. Fonar issued two series of warrants to the fund. It will file details of the transaction with the SEC. The newfound capital will be used to fund the production of Fonar’s line of MRI devices, including its Indomitable, a stand-up MRI scanner optimized for orthopedic imaging. The company announced earlier this month the sale of an Indomitable to the University of Aberdeen in Scotland.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.